Compounds > n(g),n(g')-dimethyl-l-arginine
Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Congenital Thrombotic Thrombocytopenic Purpura

n(g),n(g')-dimethyl-l-arginine has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Research Excerpts

ExcerptRelevanceReference
"Eleven patients with thrombotic thrombocytopenic purpura (TTP) or haemolytic uremic syndrome (HUS) were investigated with respect to plasma concentrations of L-arginine, a substrate for nitric oxide (NO) and asymmetrical dimethyl arginine (ADMA), during active disease and after recovery."1.30The arginine-nitric oxide pathway in thrombotic microangiopathy. ( Herlitz, H; Petersson, A; Sigström, L; Wennmalm, A; Westberg, G, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herlitz, H1
Petersson, A1
Sigström, L1
Wennmalm, A1
Westberg, G1

Other Studies

1 other study available for n(g),n(g')-dimethyl-l-arginine and Congenital Thrombotic Thrombocytopenic Purpura

ArticleYear
The arginine-nitric oxide pathway in thrombotic microangiopathy.
    Scandinavian journal of urology and nephrology, 1997, Volume: 31, Issue:5

    Topics: Adult; Aged; Arginine; Child, Preschool; Enzyme Inhibitors; Hemolytic-Uremic Syndrome; Humans; Middl

1997